Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexate.

Sigaux J, Junot C, Boissier MC, Petit M, Breckler M, Castelli F, Fenaille F, Roméo PH, Semerano L

Open source

DOI
10.1038/s41598-024-68477-6
Published
2024 Sep 9
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-024-68477-6,
  title = {Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexate.},
  author = {Sigaux J and Junot C and Boissier MC and Petit M and Breckler M and Castelli F and Fenaille F and Roméo PH and Semerano L},
  year = {2024},
  journal = {Scientific reports},
  doi = {10.1038/s41598-024-68477-6},
  url = {https://doi.org/10.1038/s41598-024-68477-6}
}

RIS

TY  - JOUR
TI  - Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexate.
AU  - Sigaux J
AU  - Junot C
AU  - Boissier MC
AU  - Petit M
AU  - Breckler M
AU  - Castelli F
AU  - Fenaille F
AU  - Roméo PH
AU  - Semerano L
PY  - 2024
JO  - Scientific reports
DO  - 10.1038/s41598-024-68477-6
UR  - https://doi.org/10.1038/s41598-024-68477-6
ER  - 

APA

J, S., C, J., MC, B., M, P., M, B., F, C., F, F., PH, R., & L, S. (2024). Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexate.. Scientific reports. https://doi.org/10.1038/s41598-024-68477-6

Source records